Neuroendocrine tumor in gastric adenoma: a diagnostic pitfall mimicking invasive adenocarcinoma
© Lee et al.; licensee BioMed Central Ltd. 2012
Received: 7 July 2012
Accepted: 8 August 2012
Published: 15 August 2012
Neuroendocrine tumor (NET) in adenoma of the gastrointestinal tract is a rare mixed glandular-endocrine neoplasm and has uncommonly been described mostly in the colon. Histologically, this tumor is composed of a predominant proportion of benign adenomatous component and a small portion of well-differentiated NE component. Only three cases of NET in gastric adenoma have been reported in the literature. We present 4 cases of NET in gastric adenoma mimicking invasive adenocarcinoma. The NETs were 0.62 mm to 4.1 mm in size and located at the basal lamina propria, muscularis mucosa and submucosa. Histologically, NETs consisted of nests, cords, tubules, and clusters of cells that predominantly interposed between the foveolar base without disturbing the overall polyp architecture. The lesions were completely removed by endoscopic submucosal dissection in three cases and in one case, subtotal gastrectomy was performed because endoscopic biopsy was invasive adenocarcinoma. The patients’ clinical course was uneventful without an evidence of recurrence or metastasis. The recognition of NET in gastric adenoma will help avoid potential diagnostic pitfalls masquerading as invasvie adenocarcinomas posed by their infiltrative pattern into submucosa.
The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1688552293761001
KeywordsNeuroendocrine tumor Adenoma Microcarcinoid Diagnosis
Although localized endocrine cell differentiation in benign or malignant glandular neoplasms of the gastrointestinal tract is relatively common, truely mixed glandular-endocrine neoplasms are rare. These tumors are composed of both glandular component like adenomas and adenocarcinomas and recognizable neuroendocrine tumor compoments. Most mixed glandular-endocrine neoplasms of the stomach are malignant tumors arising in the background of atrophic gastritis [1–5]. The histologic spectrum ranges from amphicrine carcinoma to admixture of adenoma or adenocarcinoma with neroendocrine tumor (NET) or neuroendocrine carcinoma. Only three cases of mixed benign adenoma-NET have been described in the stomach to date [6–8].
Herein, we describe the clinicopathologic features of four NETs in association with gastric adenomas, to further delineate their histologic features and discuss the diagnostic pitfalls. Recognition of this rare tumor is important not only it can be missed easily due to the minute size of the lesion but also it mimicks an invasive adenocarcinoma arising from adenoma, which may cause unnecessary surgery.
Case 1. A 64 year-old man was referred to our hospital with a 3.8 cm sized polyp in the high body after a screening upper endoscopy at outside hospital. An elevated polyp was removed in one-piece by endoscopic submucosal dissection. The patient received a repeat endoscopy at one and two year and no remnant lesion was noted.
Case 2. A 63 year-old man presented with indigestion and abdominal discomfort. Upper gastrointestinal endoscopy revealed a 0.5 cm sized elevated nodule in the lesser curvature of the antrum. The lesion was biopsied initially and endoscopioc submucosal dissection was done. The patient repeated upper gastrointestinal endoscopy at one and two year and no residual lesion was seen.
Case 3. A 52 year-old man was found out to have a 1.5 cm sized polyp in the lower body of the stomach during staging work up for rectal cancer. The patient underwent endoscopic submucosal dissection and the lesion was completely removed. The resected segment of rectum revealed a moderately differentiated adenocarcinoma and a incidentally found, separately located 0.6 cm sized NET. He received a repeat upper and lower gastrointestinal endoscopy at two year without any evidence of recurrence.
Case 4. A 65 year-old man with no family hstory of multiple endocrine neoplasia presented with chronic dyspepsia. Upper gastrointestinal endoscopy and computed tomography scan revealed a 5 cm sized gastric mass in the lesser curvature aspect of the body. Initial endoscopic biopsy diagnosis at the local clinic was well differentiated adenocarcinoma. He underwent a subtotal gastrectomy and was found to have a 5.5 cm tubulovillous adenoma. Unexpectedly, small nests of tumor cells forming a mass infiltrated into the submucosa with an invasion depth of 800 μm. All sixty regional lymph nodes procured from the resected specimen were free of tumor. The patient has no evidence of recurrence or metastasis during 12 years of follow-up.
Clinical and Pathologic Characteristics of cases with gastric adenoma-neuroendocrine tumor
Depth of invasion
TA and NET
TA and NET
TA and NET
TVA with focal AC and NET
The concept of a mixed adenoma-NET tumor of the gastrointestinal tract was first introduced by Moyana and Murphy in 1988 . Mixed glandular-endocrine neoplasms in the gastrointestinal tract have been categorized into three subtypes depending on their predominant proportions of each component by Levin et al.: composite tumors, collision tumors and amphicrine tumors . Recently, Pulitzer M et al. described “microcarcinoids”, minute NETs, in benign adenomas in cases that the neuroendocrine component is not enough to qualify for at least one third of the tumor volume, occupying a minute region of the adenomatous polyp like ours . The size of NETs in their study ranged from 5 mm to 20 mm.
We report four rare cases of gastric adenomas containing NETs with an infiltrative growth pattern mimicking adenocarcinoma. The most important reason to recognize NET in a gastric adenoma is to avoid misdiagnosis of this rare lesion as an adenocarcinoma arising from adenoma, which is more common. In our cases, some areas at the base of a polyp showed an intermixture and mergence of adenomatous glands and neuroendocrine cells, which can be misled as tumor cell pleomophism found in adenocarcinoma. These lesions appeared to be arisen from the basal epithelium of adenomas showing “budding-off” angulated glands and infiltrated into the muscularis mucosa or submucosa.
After confirmation of NET in our cases by immunohistochemistry, there was an issue to classify the proliferation of the neuroendocrine cells within adenomas depending on its size and distribution. Until now, no definite consensus on the histopathologic classification of proliferative endocrine cell lesion has been established. Solcia et al. has proposed the subclassification based on size, growth pattern, and numbers of endocrine cells within glands or crypt as follows: simple hyperplasia; linear hyperplasia; micronodular hyperplasia; dysplasia (< 0.5 mm in diameter); NET (> 0.5 mm) . Neuroendocrine components in our cases ranged from 0.62 mm to 4.1 mm. Based on Solcia et al’s classification, we could define our cases as NET.
The prognosis of benign mixed adenoma-NET of the stomach can not be completley determined due to the rarity of cases. Complete removal of an adenoma would be considered curative whereas the combined NET component would be a main predictive factor to determine the patients’ prognosis. In our four cases, three cases showed NETs limited in the lamina propria and focally extended into the muscularis mucosa without any evidence of local recurrence or metastasis. A large series by Soga et al. demonstrated that small submucosal NETs of the stomach had a relatively high metastatic rates . This study showed that the metastasis in the early-stage NETs of the stomach is correlated with not only the submucosal invasion but also the size, which is more than 10 mm. One of our 4 cases was 4.1 mm in greatest dimension and showed submucosal invasion. However, this patient underwent a subtotal gastrectomy and his sixty regional lymph nodes were free of tumor and no metastasis has been identified in a long term close follow-up for 12 years.
In summary, NET may be found in adenomas of the stomach incidentally, has characteristic morphologic features and immunoexpressions as neuroendocrine cells, and can be under or overdiagnosed due to the small size of the the lesion and overlapping histology with adenocarcinoma. This lesion can be completely treated by polypectomy or endoscopic resection technique without recurrence or metastasis. However, if the NET involves the submucosal layer, close follow-up is recommended for a relatively higher metastatic rate.
We described four rare cases of NET arising from gastric adenoma and followed benign clinical courses. Recognition of this rare entity is important for accurate diagnosis and treatment.
Written informed consents were obtained from the patients for publication of this case report and any accompanying images.
- Lee EJ, Park SM, Maeng L, Lee A, Kim KM: Composite glandular-endocrine cell carcinomas of the stomach: clinicopathologic and methylation study. APMIS. 2005, 113: 569-576. 10.1111/j.1600-0463.2005.apm_190.x.View ArticlePubMed
- Yang GC, Rotterdam H: Mixed (composite) glandular-endocrine cell carcinoma of the stomach. Report of a case and review of literature. Am J Surg Pathol. 1991, 15: 592-598. 10.1097/00000478-199106000-00008.View ArticlePubMed
- Fujiyoshi Y, Kuhara H, Eimoto T: Composite glandular-endocrine cell carcinoma of the stomach. Report of two cases with goblet cell carcinoid component. Pathol Res Pract. 2005, 200: 823-829. 10.1016/j.prp.2004.07.006.View ArticlePubMed
- Reis-Filho JS, Schmitt FC: Amphicrine gastric carcinoma. Arch Pathol Lab Med. 2001, 125: 1513-1514.PubMed
- Kim KM, Kim MJ, Cho BK, Choi SW, Rhyu MG: Genetic evidence for the multi-step progression of mixed glandular-neuroendocrine gastric carcinomas. Virchows Arch. 2002, 440: 85-93. 10.1007/s004280100540.View ArticlePubMed
- Ito H, Ito M, Tahara E: Minute carcinoid arising in gastric tubular adenoma. Histopathology. 1989, 15: 96-99. 10.1111/j.1365-2559.1989.tb03046.x.View ArticlePubMed
- Coyne JD, O’Connor B: Mixed adenoma-endocrine tumour of the stomach. Histopathology. 2010, 57: 492-494. 10.1111/j.1365-2559.2010.03630.x.View ArticlePubMed
- De Marco L, Carlinfante G, Botticelli L, Di Maira PV, Putrino I, Cavazza A: Mixed neoplasia of the stomach: description of a case of tubular adenoma combined with carcinoid. Pathologica. 2003, 95: 214-216.PubMed
- Moyana TN, Qizilbash AH, Murphy F: Composite glandular-carcinoid tumors of the colon and rectum. Report of two cases. Am J Surg Pathol. 1988, 12: 607-611. 10.1097/00000478-198808000-00001.View ArticlePubMed
- Lewin K: Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol. 1987, 11 (Suppl 1): 71-86.View ArticlePubMed
- Pulitzer M, Xu R, Suriawinata AA, Waye JD, Harpaz N: Microcarcinoids in large intestinal adenomas. Am J Surg Pathol. 2006, 30: 1531-1536. 10.1097/01.pas.0000213295.88778.00.View ArticlePubMed
- Solcia E, Bordi C, Creutzfeldt W, Dayal Y, Dayan AD, Falkmer S, Grimelius L, Havu N: Histopathological classification of nonantral gastric endocrine growths in man. Digestion. 1988, 41: 185-200. 10.1159/000199786.View ArticlePubMed
- Soga J: Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer. 2005, 103: 1587-1595. 10.1002/cncr.20939.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.